Adaptive Biotechnologies Corp
NASDAQ:ADPT
Adaptive Biotechnologies Corp
Long-Term Debt
Adaptive Biotechnologies Corp
Long-Term Debt Peer Comparison
Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors
Company | Long-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
Long-Term Debt
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Long-Term Debt
$31.3B
|
CAGR 3-Years
18%
|
CAGR 5-Years
12%
|
CAGR 10-Years
13%
|
|
Danaher Corp
NYSE:DHR
|
Long-Term Debt
$16.4B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
12%
|
CAGR 10-Years
17%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Long-Term Debt
$1.9B
|
CAGR 3-Years
7%
|
CAGR 5-Years
14%
|
CAGR 10-Years
16%
|
|
Agilent Technologies Inc
NYSE:A
|
Long-Term Debt
$2.6B
|
CAGR 3-Years
5%
|
CAGR 5-Years
7%
|
CAGR 10-Years
-1%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Long-Term Debt
$13B
|
CAGR 3-Years
1%
|
CAGR 5-Years
4%
|
CAGR 10-Years
20%
|
See Also
What is Adaptive Biotechnologies Corp's Long-Term Debt?
Long-Term Debt
0
USD
Based on the financial report for Mar 31, 2024, Adaptive Biotechnologies Corp's Long-Term Debt amounts to 0 USD.